Cancer Therapeutics to Witness Boost in Personalized Medicine
According to a new research report by RNCOS entitled, “Personalized Medicine Market Analysis”, cancer therapeutics is a major segment of the personalized medicine market. The earlier “one size fits for all” approach, that resulted in unnecessary side effects and increased healthcare expenditure due to multiple and longer hospital visits and therapy sessions, is being done away with and the new, more efficient and targeted regime of personalized medicine is being followed for the treatment of cancer.
View full press release